135 related articles for article (PubMed ID: 3312413)
1. Prophylactic immunization against experimental leishmaniasis. VI. Comparison of protective and disease-promoting T cells.
Liew FY; Hodson K; Lelchuk R
J Immunol; 1987 Nov; 139(9):3112-7. PubMed ID: 3312413
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic immunization against experimental leishmaniasis. V. Mechanism of the anti-protective blocking effect induced by subcutaneous immunization against Leishmania major infection.
Liew FY; Singleton A; Cillari E; Howard JG
J Immunol; 1985 Sep; 135(3):2102-7. PubMed ID: 3160786
[TBL] [Abstract][Full Text] [Related]
3. Distinctive cellular immunity in genetically susceptible BALB/c mice recovered from Leishmania major infection or after subcutaneous immunization with killed parasites.
Liew FY; Dhaliwal JS
J Immunol; 1987 Jun; 138(12):4450-6. PubMed ID: 3295049
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic immunization against experimental leishmaniasis. III. Protection against fatal Leishmania tropica infection induced by irradiated promastigotes involves Lyt-1+2- T cells that do not mediate cutaneous DTH.
Liew FY; Howard JG; Hale C
J Immunol; 1984 Jan; 132(1):456-61. PubMed ID: 6228580
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic immunization against experimental leishmaniasis. IV. Subcutaneous immunization prevents the induction of protective immunity against fatal Leishmania major infection.
Liew FY; Hale C; Howard JG
J Immunol; 1985 Sep; 135(3):2095-101. PubMed ID: 4020140
[TBL] [Abstract][Full Text] [Related]
6. Vaccination against murine cutaneous leishmaniasis by using Leishmania major antigen/liposomes. Optimization and assessment of the requirement for intravenous immunization.
Kahl LP; Scott CA; Lelchuk R; Gregoriadis G; Liew FY
J Immunol; 1989 Jun; 142(12):4441-9. PubMed ID: 2786033
[TBL] [Abstract][Full Text] [Related]
7. Vaccination against cutaneous leishmaniasis in a murine model. I. Induction of protective immunity with a soluble extract of promastigotes.
Scott P; Pearce E; Natovitz P; Sher A
J Immunol; 1987 Jul; 139(1):221-7. PubMed ID: 3495599
[TBL] [Abstract][Full Text] [Related]
8. L3T4+ T cells promoting susceptibility to murine cutaneous leishmaniasis express the surface marker Ly-24 (Pgp-1).
Moll H; Scollay R
Eur J Immunol; 1989 Feb; 19(2):307-14. PubMed ID: 2467816
[TBL] [Abstract][Full Text] [Related]
9. Dual regulation of resistance against Toxoplasma gondii infection by Lyt-2+ and Lyt-1+, L3T4+ T cells in mice.
Suzuki Y; Remington JS
J Immunol; 1988 Jun; 140(11):3943-6. PubMed ID: 3259601
[TBL] [Abstract][Full Text] [Related]
10. Higher frequency of Leishmania major-specific L3T4+ T cells in susceptible BALB/c as compared with resistant CBA mice.
Milon G; Titus RG; Cerottini JC; Marchal G; Louis JA
J Immunol; 1986 Feb; 136(4):1467-71. PubMed ID: 2418115
[TBL] [Abstract][Full Text] [Related]
11. Macrophage activation by interferon-gamma from host-protective T cells is inhibited by interleukin (IL)3 and IL4 produced by disease-promoting T cells in leishmaniasis.
Liew FY; Millott S; Li Y; Lelchuk R; Chan WL; Ziltener H
Eur J Immunol; 1989 Jul; 19(7):1227-32. PubMed ID: 2503386
[TBL] [Abstract][Full Text] [Related]
12. Protection against Leishmania major in BALB/c mice by adoptive transfer of a T cell clone recognizing a low molecular weight antigen released by promastigotes.
Scott P; Caspar P; Sher A
J Immunol; 1990 Feb; 144(3):1075-9. PubMed ID: 2295814
[TBL] [Abstract][Full Text] [Related]
13. Immunization of susceptible hosts with a soluble antigen fraction from Leishmania major leads to aggravation of murine leishmaniasis mediated by CD4+ T cells.
Bogdan C; Schröppel K; Lohoff M; Röllinghoff M; Solbach W
Eur J Immunol; 1990 Dec; 20(12):2533-40. PubMed ID: 1980108
[TBL] [Abstract][Full Text] [Related]
14. Immunologic regulation of experimental cutaneous leishmaniasis. V. Characterization of effector and specific suppressor T cells.
Liew FY; Hale C; Howard JG
J Immunol; 1982 Apr; 128(4):1917-22. PubMed ID: 6120976
[TBL] [Abstract][Full Text] [Related]
15. Analysis of variables associated with promotion of resistance and its abrogation in T cell-reconstituted nude mice infected with Leishmania major.
Moll H; Mitchell GF
J Parasitol; 1988 Dec; 74(6):993-8. PubMed ID: 3264023
[TBL] [Abstract][Full Text] [Related]
16. Suppressive effect of cyclosporin A on the development of Leishmania tropica-induced lesions in genetically susceptible BALB/c mice.
Solbach W; Forberg K; Kammerer E; Bogdan C; Röllinghoff M
J Immunol; 1986 Jul; 137(2):702-7. PubMed ID: 3487578
[TBL] [Abstract][Full Text] [Related]
17. Role of L3T4+ and LyT-2+ cells in experimental visceral leishmaniasis.
Stern JJ; Oca MJ; Rubin BY; Anderson SL; Murray HW
J Immunol; 1988 Jun; 140(11):3971-7. PubMed ID: 3131421
[TBL] [Abstract][Full Text] [Related]
18. Targeted activation of CD8 cells and infection of beta 2-microglobulin-deficient mice fail to confirm a primary protective role for CD8 cells in experimental leishmaniasis.
Wang ZE; Reiner SL; Hatam F; Heinzel FP; Bouvier J; Turck CW; Locksley RM
J Immunol; 1993 Aug; 151(4):2077-86. PubMed ID: 8102158
[TBL] [Abstract][Full Text] [Related]
19. Contrasuppressor cells that break oral tolerance are antigen-specific T cells distinct from T helper (L3T4+), T suppressor (Lyt-2+), and B cells.
Kitamura K; Kiyono H; Fujihashi K; Eldridge JH; Green DR; McGhee JR
J Immunol; 1987 Nov; 139(10):3251-9. PubMed ID: 3500210
[TBL] [Abstract][Full Text] [Related]
20. Macrophages as effector cells of protective immunity in murine schistosomiasis. VI. T cell-dependent, lymphokine-mediated, activation of macrophages in response to Schistosoma mansoni antigens.
James SL; Lazdins JK; Hieny S; Natovitz P
J Immunol; 1983 Sep; 131(3):1481-6. PubMed ID: 6350456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
